Floatz logo

Therapeutic Asset Ratings

251 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Ethiodized Oil
Narrow Margin
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP3B (60)
Ethiodized Oil
Radiotherapy, Adjuvant
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP3B (60)
Theprubicin
Immune Checkpoint Inhibitor
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP3B (60)
Theprubicin
Narrow Margin
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP3B (60)
Theprubicin
Radiotherapy, Adjuvant
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP3B (60)
Adebrelimab
HR Positive/HER2 Low Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2B (60)
Vinorelbine
Brain Metastases
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2B (60)
Mitoxantrone
Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP3B (59)
Fluzoparib
Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2B (59)
Mitoxantrone
Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP3B (58)
Cyclophosphamide
Radiotherapy
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2B (58)
Romiplostim
Chemotherapy-Induced Thrombocytopenia
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2B (58)
Tucidinostat
Chemotherapy Effect
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2B (58)
Capecitabine
Rectal Diseases
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2B (57)
Eloxatin
Oxaliplatin
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2B (57)
Eloxatin
Rectal Diseases
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2B (57)
FLUOROURACILUM
Oxaliplatin
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2B (57)
Pyrotinib
Tumor Thrombosis
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2B (57)
rc48-adc
Tumor Thrombosis
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2B (57)
Tislelizumab
Tumor Thrombosis
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2B (57)
Pyrotinib
Pyrotinib Treatment
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2/3B (57)
Romiplostim
Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2B (56)
Cyclophosphamide
Neuroendocrine Tumors
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2CCC (55)
Epirubicin
Radiotherapy
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2CCC (55)
Fludarabine
Neuroendocrine Tumors
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2CCC (55)
Showing 26 to 50 of 251 assets
PreviousPage 2 of 11Next